Programme Content
The program consists of 3 days totaling 24 equivalent hours and is built on 3 pillars:
About Programme
Healthcare systems are under increasing pressure to ensure timely and equitable access to innovative health technologies while maintaining financial sustainability. As advanced therapies and high-cost medicines reshape the healthcare landscape, pricing and payment models have become strategic tools to balance innovation, affordability and access.
This program provides a comprehensive understanding of the latest pricing and reimbursement approaches adopted across Europe, equipping participants with the knowledge and practical tools needed to navigate increasingly complex market access decisions.
This program will enable you to:
Understand and critically evaluate the key concepts, models and policy approaches in the pricing and payment of pharmaceuticals and medical devices across different healthcare systems.
Analyze the interests, roles and decision-making logics of the stakeholders involved in pricing and market access processes.
Identify, access and navigate key resources, databases and tools available at national and international levels to support evidence-informed decisions on pricing and payment of health technologies.
Assess the most appropriate pricing and payment schemes according to different health technologies, objectives and contexts.
Interpret and leverage international trends and regulatory developments to inform pricing strategies.
Develop the negotiation and communication skills required to engage effectively and confidently with public- and private-sector stakeholders on pricing, reimbursement and access issues.
Understand and critically evaluate the key concepts, models and policy approaches in the pricing and payment of pharmaceuticals and medical devices across different healthcare systems.
Analyze the interests, roles and decision-making logics of the stakeholders involved in pricing and market access processes.
Identify, access and navigate key resources, databases and tools available at national and international levels to support evidence-informed decisions on pricing and payment of health technologies.
Assess the most appropriate pricing and payment schemes according to different health technologies, objectives and contexts.
Interpret and leverage international trends and regulatory developments to inform pricing strategies.
Develop the negotiation and communication skills required to engage effectively and confidently with public- and private-sector stakeholders on pricing, reimbursement and access issues.
Programme Audience
This program is designed for professionals working in pricing, reimbursement and market access of pharmaceuticals and medical devices, including managers and specialists involved in pricing negotiations, value dossier development and market access strategies. It is also intended for professionals wishing to develop a broader understanding of the regulatory, economic and strategic dimensions that shape pricing and reimbursement decisions across European healthcare systems.
Other programs in this subject area you might find useful
Same topic, Similar duration - Broader exploration across all institutes
Contact us for the further details
Speak with an Advisor
- Pedagogy (case method, experiential learning, coaching, simulations)
- Programme Objective
- Faculty Information
- Testimonials
- Programme Benefits
- Brochure
Prashansa Uttam
Programme Advisor
SDA Bocconi School of Management
Executive Education Office
Tell us about your program enquiry
Fill out the form below and our team will get back to you within 24 hours.
